Tumor Board Participation Among Physicians Caring for Patients With Lung or Colorectal Cancer
- 1 May 2015
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 11 (3) , e267-e278
Abstract
Among patients with lung or colorectal cancer, frequent physician tumor board engagement was associated with patient clinical trial participation and higher rates of curative-intent surgery for stage I to II NSCLC but not with overall survival.Keywords
This publication has 23 references indexed in Scilit:
- Physician and Practice Characteristics Influencing Tumor Board Attendance: Results From the Provider Survey of the Los Angeles Women's Health StudyJournal of Oncology Practice, 2011
- Patients' Experiences With Care for Lung Cancer and Colorectal Cancer: Findings From the Cancer Care Outcomes Research and Surveillance ConsortiumJournal of Clinical Oncology, 2010
- A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group ProgramJNCI: Journal of the National Cancer Institute, 2010
- Multiple imputation in a large-scale complex survey: a practical guideStatistical Methods in Medical Research, 2009
- Adjuvant Chemotherapy for Stage III Colon Cancer: Do Physicians Agree About the Importance of Patient Age and Comorbidity?Journal of Clinical Oncology, 2008
- Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic CancerAnnals of Surgical Oncology, 2008
- Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor boardCancer, 2006
- Understanding Cancer Treatment and Outcomes: The Cancer Care Outcomes Research and Surveillance ConsortiumJournal of Clinical Oncology, 2004
- Psychometric Properties of the CAHPS™ 1.0 Survey MeasuresMedical Care, 1999
- The Role of the Tumor Board In a Community HospitalCA: A Cancer Journal for Clinicians, 1987